Cibus (CBUS) Projected to Post Earnings on Thursday

Cibus (NASDAQ:CBUS - Get Free Report) will likely be announcing its earnings results before the market opens on Thursday, March 20th. Analysts expect the company to announce earnings of ($0.68) per share and revenue of $1.13 million for the quarter. Investors that are interested in participating in the company's conference call can do so using this link.

Cibus Price Performance

NASDAQ CBUS opened at $2.16 on Thursday. The firm has a market cap of $57.14 million, a PE ratio of -0.10 and a beta of 2.04. Cibus has a one year low of $1.80 and a one year high of $23.18. The stock's 50 day simple moving average is $2.41 and its 200 day simple moving average is $3.56.

Institutional Trading of Cibus

A hedge fund recently raised its stake in Cibus stock. Bank of America Corp DE increased its holdings in Cibus, Inc. (NASDAQ:CBUS - Free Report) by 113.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 35,536 shares of the company's stock after acquiring an additional 18,885 shares during the period. Bank of America Corp DE owned about 0.13% of Cibus worth $99,000 at the end of the most recent quarter. Institutional investors own 33.81% of the company's stock.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group cut their price target on Cibus from $20.00 to $18.00 and set a "buy" rating on the stock in a research note on Wednesday, January 22nd.

Remove Ads

About Cibus

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.